Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Non-invasive Aesthetic Treatment Market, by End-use
1.4.2 Global Non-invasive Aesthetic Treatment Market, by Procedure
1.4.3 Global Non-invasive Aesthetic Treatment Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Product Launches and Product Expansions
3.2.2 Acquisition and Mergers
3.2.3 Partnerships, Collaborations and Agreements
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2017, Sep – 2022, Feb) Leading Players
Chapter 4. Global Non-invasive Aesthetic Treatment Market by End-use
4.1 Global MedSpa Market by Region
4.2 Global Hospital/Surgery Center Market by Region
4.3 Global Traditional Spa Market by Region
4.4 Global HCP Owned Clinic Market by Region
Chapter 5. Global Non-invasive Aesthetic Treatment Market by Procedure
5.1 Global Injectables Market by Region
5.2 Global Skin Rejuvenation Market by Region
5.3 Global Others Market by Region
Chapter 6. Global Non-invasive Aesthetic Treatment Market by Region
6.1 North America Non-invasive Aesthetic Treatment Market
6.1.1 North America Non-invasive Aesthetic Treatment Market by End-use
6.1.1.1 North America MedSpa Market by Country
6.1.1.2 North America Hospital/Surgery Center Market by Country
6.1.1.3 North America Traditional Spa Market by Country
6.1.1.4 North America HCP Owned Clinic Market by Country
6.1.2 North America Non-invasive Aesthetic Treatment Market by Procedure
6.1.2.1 North America Injectables Market by Country
6.1.2.2 North America Skin Rejuvenation Market by Country
6.1.2.3 North America Others Market by Country
6.1.3 North America Non-invasive Aesthetic Treatment Market by Country
6.1.3.1 US Non-invasive Aesthetic Treatment Market
6.1.3.1.1 US Non-invasive Aesthetic Treatment Market by End-use
6.1.3.1.2 US Non-invasive Aesthetic Treatment Market by Procedure
6.1.3.2 Canada Non-invasive Aesthetic Treatment Market
6.1.3.2.1 Canada Non-invasive Aesthetic Treatment Market by End-use
6.1.3.2.2 Canada Non-invasive Aesthetic Treatment Market by Procedure
6.1.3.3 Mexico Non-invasive Aesthetic Treatment Market
6.1.3.3.1 Mexico Non-invasive Aesthetic Treatment Market by End-use
6.1.3.3.2 Mexico Non-invasive Aesthetic Treatment Market by Procedure
6.1.3.4 Rest of North America Non-invasive Aesthetic Treatment Market
6.1.3.4.1 Rest of North America Non-invasive Aesthetic Treatment Market by End-use
6.1.3.4.2 Rest of North America Non-invasive Aesthetic Treatment Market by Procedure
6.2 Europe Non-invasive Aesthetic Treatment Market
6.2.1 Europe Non-invasive Aesthetic Treatment Market by End-use
6.2.1.1 Europe MedSpa Market by Country
6.2.1.2 Europe Hospital/Surgery Center Market by Country
6.2.1.3 Europe Traditional Spa Market by Country
6.2.1.4 Europe HCP Owned Clinic Market by Country
6.2.2 Europe Non-invasive Aesthetic Treatment Market by Procedure
6.2.2.1 Europe Injectables Market by Country
6.2.2.2 Europe Skin Rejuvenation Market by Country
6.2.2.3 Europe Others Market by Country
6.2.3 Europe Non-invasive Aesthetic Treatment Market by Country
6.2.3.1 Germany Non-invasive Aesthetic Treatment Market
6.2.3.1.1 Germany Non-invasive Aesthetic Treatment Market by End-use
6.2.3.1.2 Germany Non-invasive Aesthetic Treatment Market by Procedure
6.2.3.2 UK Non-invasive Aesthetic Treatment Market
6.2.3.2.1 UK Non-invasive Aesthetic Treatment Market by End-use
6.2.3.2.2 UK Non-invasive Aesthetic Treatment Market by Procedure
6.2.3.3 France Non-invasive Aesthetic Treatment Market
6.2.3.3.1 France Non-invasive Aesthetic Treatment Market by End-use
6.2.3.3.2 France Non-invasive Aesthetic Treatment Market by Procedure
6.2.3.4 Russia Non-invasive Aesthetic Treatment Market
6.2.3.4.1 Russia Non-invasive Aesthetic Treatment Market by End-use
6.2.3.4.2 Russia Non-invasive Aesthetic Treatment Market by Procedure
6.2.3.5 Spain Non-invasive Aesthetic Treatment Market
6.2.3.5.1 Spain Non-invasive Aesthetic Treatment Market by End-use
6.2.3.5.2 Spain Non-invasive Aesthetic Treatment Market by Procedure
6.2.3.6 Italy Non-invasive Aesthetic Treatment Market
6.2.3.6.1 Italy Non-invasive Aesthetic Treatment Market by End-use
6.2.3.6.2 Italy Non-invasive Aesthetic Treatment Market by Procedure
6.2.3.7 Rest of Europe Non-invasive Aesthetic Treatment Market
6.2.3.7.1 Rest of Europe Non-invasive Aesthetic Treatment Market by End-use
6.2.3.7.2 Rest of Europe Non-invasive Aesthetic Treatment Market by Procedure
6.3 Asia Pacific Non-invasive Aesthetic Treatment Market
6.3.1 Asia Pacific Non-invasive Aesthetic Treatment Market by End-use
6.3.1.1 Asia Pacific MedSpa Market by Country
6.3.1.2 Asia Pacific Hospital/Surgery Center Market by Country
6.3.1.3 Asia Pacific Traditional Spa Market by Country
6.3.1.4 Asia Pacific HCP Owned Clinic Market by Country
6.3.2 Asia Pacific Non-invasive Aesthetic Treatment Market by Procedure
6.3.2.1 Asia Pacific Injectables Market by Country
6.3.2.2 Asia Pacific Skin Rejuvenation Market by Country
6.3.2.3 Asia Pacific Others Market by Country
6.3.3 Asia Pacific Non-invasive Aesthetic Treatment Market by Country
6.3.3.1 China Non-invasive Aesthetic Treatment Market
6.3.3.1.1 China Non-invasive Aesthetic Treatment Market by End-use
6.3.3.1.2 China Non-invasive Aesthetic Treatment Market by Procedure
6.3.3.2 Japan Non-invasive Aesthetic Treatment Market
6.3.3.2.1 Japan Non-invasive Aesthetic Treatment Market by End-use
6.3.3.2.2 Japan Non-invasive Aesthetic Treatment Market by Procedure
6.3.3.3 India Non-invasive Aesthetic Treatment Market
6.3.3.3.1 India Non-invasive Aesthetic Treatment Market by End-use
6.3.3.3.2 India Non-invasive Aesthetic Treatment Market by Procedure
6.3.3.4 South Korea Non-invasive Aesthetic Treatment Market
6.3.3.4.1 South Korea Non-invasive Aesthetic Treatment Market by End-use
6.3.3.4.2 South Korea Non-invasive Aesthetic Treatment Market by Procedure
6.3.3.5 Singapore Non-invasive Aesthetic Treatment Market
6.3.3.5.1 Singapore Non-invasive Aesthetic Treatment Market by End-use
6.3.3.5.2 Singapore Non-invasive Aesthetic Treatment Market by Procedure
6.3.3.6 Malaysia Non-invasive Aesthetic Treatment Market
6.3.3.6.1 Malaysia Non-invasive Aesthetic Treatment Market by End-use
6.3.3.6.2 Malaysia Non-invasive Aesthetic Treatment Market by Procedure
6.3.3.7 Rest of Asia Pacific Non-invasive Aesthetic Treatment Market
6.3.3.7.1 Rest of Asia Pacific Non-invasive Aesthetic Treatment Market by End-use
6.3.3.7.2 Rest of Asia Pacific Non-invasive Aesthetic Treatment Market by Procedure
6.4 LAMEA Non-invasive Aesthetic Treatment Market
6.4.1 LAMEA Non-invasive Aesthetic Treatment Market by End-use
6.4.1.1 LAMEA MedSpa Market by Country
6.4.1.2 LAMEA Hospital/Surgery Center Market by Country
6.4.1.3 LAMEA Traditional Spa Market by Country
6.4.1.4 LAMEA HCP Owned Clinic Market by Country
6.4.2 LAMEA Non-invasive Aesthetic Treatment Market by Procedure
6.4.2.1 LAMEA Injectables Market by Country
6.4.2.2 LAMEA Skin Rejuvenation Market by Country
6.4.2.3 LAMEA Others Market by Country
6.4.3 LAMEA Non-invasive Aesthetic Treatment Market by Country
6.4.3.1 Brazil Non-invasive Aesthetic Treatment Market
6.4.3.1.1 Brazil Non-invasive Aesthetic Treatment Market by End-use
6.4.3.1.2 Brazil Non-invasive Aesthetic Treatment Market by Procedure
6.4.3.2 Argentina Non-invasive Aesthetic Treatment Market
6.4.3.2.1 Argentina Non-invasive Aesthetic Treatment Market by End-use
6.4.3.2.2 Argentina Non-invasive Aesthetic Treatment Market by Procedure
6.4.3.3 UAE Non-invasive Aesthetic Treatment Market
6.4.3.3.1 UAE Non-invasive Aesthetic Treatment Market by End-use
6.4.3.3.2 UAE Non-invasive Aesthetic Treatment Market by Procedure
6.4.3.4 Saudi Arabia Non-invasive Aesthetic Treatment Market
6.4.3.4.1 Saudi Arabia Non-invasive Aesthetic Treatment Market by End-use
6.4.3.4.2 Saudi Arabia Non-invasive Aesthetic Treatment Market by Procedure
6.4.3.5 South Africa Non-invasive Aesthetic Treatment Market
6.4.3.5.1 South Africa Non-invasive Aesthetic Treatment Market by End-use
6.4.3.5.2 South Africa Non-invasive Aesthetic Treatment Market by Procedure
6.4.3.6 Nigeria Non-invasive Aesthetic Treatment Market
6.4.3.6.1 Nigeria Non-invasive Aesthetic Treatment Market by End-use
6.4.3.6.2 Nigeria Non-invasive Aesthetic Treatment Market by Procedure
6.4.3.7 Rest of LAMEA Non-invasive Aesthetic Treatment Market
6.4.3.7.1 Rest of LAMEA Non-invasive Aesthetic Treatment Market by End-use
6.4.3.7.2 Rest of LAMEA Non-invasive Aesthetic Treatment Market by Procedure
Chapter 7. Company Profiles
7.1 Alma Lasers Ltd. (Sisram Medical Ltd.)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Product Launches and Product Expansions:
7.1.5.2 Approvals and Agreements:
7.1.5.3 Acquisitions and Mergers:
7.1.5.4 Partnerships, Collaborations and Agreements:
7.2 Allergan PLC (AbbVie)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisitions and Mergers:
7.2.5.2 Product Launches and Product Expansions:
7.2.5.3 Approvals and Trials:
7.3 Galderma S.A.
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Partnerships, Collaborations and Agreements:
7.4 Merz Pharma GmbH & Co. KGaA
7.4.1 Company Overview
7.4.2 Recent strategies and developments:
7.4.2.1 Product Launches and Product Expansions:
7.5 Johnson & Johnson
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental &Regional Analysis
7.5.4 Research & Development Expenses
7.6 Candela Medical Corporation
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Acquisitions and Mergers:
7.6.2.2 Partnerships, Collaborations and Agreements:
7.7 Bausch Health Companies, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Cutera, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Product Launches and Product Expansions:
7.9 Lumenis Ltd.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Product Launches and Product Expansions:
7.10. Hologic, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Acquisitions and Mergers:
7.10.5.2 Product Launches and Product Expansions:
Unique Offerings 